These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 4995960)

  • 41. Effective and ineffective systems of in vitro testing for antilymphocyte globulin (ALG) potency: correlation of mixed agglutination and primate skin graft testing.
    Millington M; Thomas FT; Berry R; Thomas JM; Lee HM
    Surg Forum; 1977; 28():329-31. PubMed ID: 103222
    [No Abstract]   [Full Text] [Related]  

  • 42. Transplantation antigens in the chacma baboon Papio ursinus Kerr.
    Downing HJ; Burgess BJ; Vos GH; Burgers LE; Webb GR
    Transplant Proc; 1974 Jun; 6(2):169-72. PubMed ID: 4275460
    [No Abstract]   [Full Text] [Related]  

  • 43. ALG treatment of Rhesus monkeys. Attempts to reduce complications by the induction of tolerance.
    Balner H; Yron I; Dersjant H; Zaalberg O; Betel I
    Transplantation; 1970 Nov; 10(5):416-24. PubMed ID: 4992451
    [No Abstract]   [Full Text] [Related]  

  • 44. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
    Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
    Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
    [No Abstract]   [Full Text] [Related]  

  • 45. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 46. [Recent studies concerning the effect of phytohemagglutinins (PHA) on the rosette E formation from the part of peripheral human lymphocytes].
    Manconi PE; Del Giacco GS; Tognella S; Mantovani G; Fadda MF; Cornaglia P; Zicca A; Zaccheo D; Grifoni V
    Boll Ist Sieroter Milan; 1976 Mar; 55(71):32-7. PubMed ID: 1088076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antisera against subcellular lymphocyte fractions in rats and extension to horse antihuman ALS.
    Halbfass HJ; Staib I; Heinze V; Michaelis W; Herfarth C; Vonend E
    Bull Soc Int Chir; 1973; 32(2):186-94. PubMed ID: 4578773
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 49. The inhibition of formation of migration inhibiting factor (MIF) by various antilymphocyte sera.
    Pekárek J; Svejcar J; Johanovský J
    Immunology; 1971 Jun; 20(6):895-900. PubMed ID: 5314711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of heterologous anti-mouse lymphocyte serum (ALS) in studies of tumorogenic potentials of C3H murine cells propagated in vitro.
    Radzikowski C; Kieler J
    Arch Immunol Ther Exp (Warsz); 1972; 20(4):473-84. PubMed ID: 5078889
    [No Abstract]   [Full Text] [Related]  

  • 51. Rabbit antilymphocyte and antithymocyte serum pools prepared to 1,5-difluoro-2,4-dinitrobenzene-treated cells.
    Rule AH; Gozzo JJ; Woods JE
    Transplantation; 1973 Jun; 15(6):531-3. PubMed ID: 4577152
    [No Abstract]   [Full Text] [Related]  

  • 52. A quantitative study of the binding of ALS to various cell types.
    Skamene E; Russell PS
    Clin Exp Immunol; 1971 Feb; 8(2):195-204. PubMed ID: 4102255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anomalous reactivity of certain HL-A typing sera with leukemic lymphocytes.
    Walford RL; Waters H; Smith GS; Sturgeon P
    Tissue Antigens; 1973; 3(3):222-34. PubMed ID: 4203771
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement.
    Koene RA; Gerlag PG; Hagemann JF; van Haelst UJ; Wijdeveld PG
    J Immunol; 1973 Aug; 111(2):520-6. PubMed ID: 4577882
    [No Abstract]   [Full Text] [Related]  

  • 55. [Recognition of antigen in vivo by cells forming spontaneous rosettes].
    Bach JF; Dardenne M; Muller JY
    C R Acad Hebd Seances Acad Sci D; 1970 Apr; 270(17):2142-4. PubMed ID: 4987006
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparative effectiveness of anti-lymphocyte serum (A.L.S.) and imuran with respect to suppression of hemagglutinin formation and skin homograft rejection.
    Israel DE; de Vries MJ
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):102-4. PubMed ID: 4392611
    [No Abstract]   [Full Text] [Related]  

  • 57. Standardized horse antihuman lymphocyte globulin for clinical use.
    Wilson S; Laurie G; Logan L
    Transplantation; 1973 Nov; 16(5):466-75. PubMed ID: 4201844
    [No Abstract]   [Full Text] [Related]  

  • 58. Mode of action of antilymphocyte serum.
    DeMeester TR
    Surg Gynecol Obstet; 1969 Oct; 129(4):717-22. PubMed ID: 4898242
    [No Abstract]   [Full Text] [Related]  

  • 59. [Complement system and lymphocytotoxic antibodies in presensitized dogs after homologous lung transplantation ].
    Möschl P; Keiler A; Lubec G; Mayr WR; Salem G; Szalay S; Glöckler M
    Wien Klin Wochenschr; 1977 Jan; 89(1):1-7. PubMed ID: 319602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers.
    Mellstedt H; Jondal M; Holm G
    Clin Exp Immunol; 1973 Nov; 15(3):321-30. PubMed ID: 4543556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.